503A Price Audit Verified: Semaglutide $49/mo · Tirzepatide $99/mo ($0 Platform Membership · All Doses Locked) Claim $49 Rate →
Losing Weight RX Open-Data Desk
Zero-Dependency Pharmacoeconomic Tool · Powered by DOI 10.5281/zenodo.24139315

GLP-1 52-Week Dose-Titration & Cost-Per-Milligram ($/mg) Calculator (2026)

Calculate your exact $/mg active yield and 52-week total spend across 0.25–2.4 mg Semaglutide and 2.5–15 mg Tirzepatide vs tiered subscription clinics.

LWR Cost Per Active mg
$5.10/mg
Competitor Cost Per mg
$46.25/mg
Your 52-Week Savings
$4,740

Underlying Empirical Dataset Citation

All default provider rates, PBM thresholds, and bioavailability coefficients in this tool are drawn directly from our open-access CC-BY-4.0 dataset (glp1-dose-titration-cost-per-mg-yield-2026 · Academic DOI 10.5281/zenodo.24139315).

Ready to Lock In Your Verified Flat Rate?

$0 platform membership, $0 high-dose escalation surcharges, and free express cold-chain shipping.

Lock $49 Sema / $99 Tirz Across All Doses →

Clinical & Regulatory References

The clinical efficacy, dosing, safety, and regulatory information in GLP-1 52-Week Dose-Titration & Cost-Per-Milligram ($/mg) Calculator (2026) is supported by the following peer-reviewed studies and authoritative .gov / .edu sources:

  1. Mullins, G. R., Hodsdon, M. E., Li, Y. G., Anglin, G., Urva, S., Schneck, K., Bardos, J. N., Martins, R. F., Brown, K., & Calderon, B. (2024). Tirzepatide Immunogenicity on Pharmacokinetics, Efficacy, and Safety: Analysis of Data From Phase 3 Studies. The Journal of clinical endocrinology and metabolism, 109(2), 361-369. https://doi.org/10.1210/clinem/dgad532
  2. National Heart, Lung, and Blood Institute, National Institutes of Health. (2024). Calculate your body mass index (BMI). https://www.nhlbi.nih.gov/health/educational/lose_wt/BMI/bmicalc.htm
  3. National Institute of Diabetes and Digestive and Kidney Diseases. (2023). Prescription medications to treat overweight and obesity. https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity
  4. O'Neil, P. M., Birkenfeld, A. L., McGowan, B., Mosenzon, O., Pedersen, S. D., Wharton, S., Carson, C. G., Jepsen, C. H., Kabisch, M., & Wilding, J. P. H. (2018). Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. Lancet (London, England), 392(10148), 637-649. https://doi.org/10.1016/S0140-6736(18)31773-2
  5. Samuels, J. M., Ye, F., Irlmeier, R., Silver, H., Srivastava, G., & Spann, M. (2025). Real-world titration, persistence & weight loss of semaglutide and tirzepatide in an academic obesity clinic. Diabetes, obesity & metabolism, 27(11), 6200-6209. https://doi.org/10.1111/dom.70004
  6. UCLA Health. (2024). Semaglutide for weight loss: What you need to know. https://www.uclahealth.org/news/article/semaglutide-weight-loss-what-you-need-know